Tumor necrosis factor (TNF) inhibitors are increasingly used in psoriasis treatment. We describe a patient with psoriasis and diabetes mellitus (DM) who developed recurrent hyperglycemia during adalimumab treatment.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: